PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Ethanol and water extracts attenuated free fatty acid-induced steatosis in HepG2 cells and reduced body weight, hepatic lipids, and dyslipidemia in high-fat diet-induced obese mice [PMID:30668424, 35678694]
Aqueous extracts protected against renal damage and podocyte injury by inhibiting the TGF-β1 signaling pathway in rat models [PMID:31632540, 23827664]
Ameliorated DNCB-induced dermatitis in BALB/c mice by inhibiting mast cell and eosinophil infiltration [PMID:34581418]
Water extract inhibited osteoclastogenesis in RAW 264.7 cells and reduced bone loss in ovariectomized rat models [PMID:30915145]
Attenuated retinal optic disc cell apoptosis, oxidative stress, and inflammation in diabetic rats [PMID:31307239]
Evidence summary
PubMed sources
- 1.PMID: 30668424 (2019) — Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice. · Phytomedicine : international journal of phytotherapy and phytopharmacology
- 2.PMID: 34503410 (2022) — Effect of Fractions from Lycopus lucidus Turcz. Leaves on Genomic DNA Oxidation and Matrix Metalloproteinase Activity. · Combinatorial chemistry & high throughput screening
- 3.PMID: 34581418 (2021) — Lycopus lucidus Turcz ameliorates DNCB‑induced atopic dermatitis in BALB/c mice. · Molecular medicine reports
- 4.PMID: 15022718 (2004) — Antioxidative constituents from Lycopus lucidus. · Archives of pharmacal research
- 5.PMID: 27262082